This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2011 by Brainsway.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Brainsway Identifier:
First received: October 25, 2011
Last updated: January 26, 2015
Last verified: November 2011
This is a first feasibility study in order to test if deep Transcranial Magnetic Stimulation (TMS) treatment with high frequency (10Hz) will improve the symptoms of patient MCI (Mild Cognitive impairment). The hypothesis of the study is that high frequency treatment with deep TMS will improve the daily functioning of patients who suffers from MCI.

Condition Intervention Phase
Mild Cognitive Impairment Device: H-Coil Deep TMS Device: SHAM Coil TMS Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Official Title: Feasibility Study in Order to Test the Efficiency of Deep TMS on Patient With MCI

Further study details as provided by Brainsway:

Primary Outcome Measures:
  • Mindstreams [ Time Frame: the test will be assessed on visit 17 which means 4 month from baseline ]
    Mindstreams test is designed to test the I.Q change of the patients from baseline

Secondary Outcome Measures:
  • CDR - Clinical Dementia Rating [ Time Frame: the test will be assessed on visit 17 which means 4 month from baseline ]
    CDR test is designed to test the dementia severity of the patients from baseline

Estimated Enrollment: 30
Study Start Date: November 2011
Estimated Study Completion Date: November 2015
Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Real TMS
this group will receive high frequency deep TMS treatment of 10HZ
Device: H-Coil Deep TMS
this group will receive high frequency treatment of deep TMS with 10Hz
Sham Comparator: SHAM TMS
this group will receive SHAM treatment of deep TMS
Device: SHAM Coil TMS
this group will receive SHAM treatment of deep TMS


Ages Eligible for Study:   55 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Men and women 50-80 years of age.
  2. Self reporting of the patient about memory deterioration, without any damage of daily lify functioning.
  3. Scored of one standard deviation below the average (according to standardization of age and years of schooling) in the memory index and Mindstream test, without any major damage of other cognitive function)
  4. score >= 24 in MMSE (Mini Mental State Examination) test.
  5. Preserved Cognitive and executive functioning, without dementia according to DSM -IV
  6. Lack of other reason for memory deterioration like acute affect disorder or other neurological disorders, according to the doctor diagnosis.
  7. Score of maximum 0.5 in the Clinical Dementia Rating. in this test the score of the memory index will be 0.5 or 1, and not more then 1 point in two other index of this test.
  8. Capable and willing to provide informed consent.

Exclusion Criteria:

  1. Any other Axis I diagnosis as the primary diagnosis
  2. Any medications that can cause a risk of seizure. for instance, anti psychotic medication, high dosage of anti depression medication
  3. History of non tolerance for TMS treatment
  4. Diagnosis of Severe personality disorder according to DSM-IV
  5. current suicidal tendency
  6. Uncontrolled hypertension
  7. History of epilepsy, seizure, or heat convulsion
  8. History of epilepsy or seizure in first degree relatives
  9. History of head injury or stroke
  10. History of metal implants in the head (except dental fillings)
  11. History of surgery entailing metallic implants or known history of any metallic particles in the eye, implanted cardiac pacemaker, cochlear implants, use of neurostimulators, or any medical pumps
  12. History of drug or alcohol abuse
  13. Inadequate communication with examiner
  14. Participation in another clinical study, either concurrent with this trial or in the 3 months preceding it
  15. Inability to sign a consent form
  16. Women of childbearing potential and not using a medically accepted form of contraception when engaging in sexual intercourse
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01464515

Contact: Ellisa Ash, Dr. +97236973698

Ichilov Hospital, Neurological Department Recruiting
Tel Aviv, Israel
Contact: Elissa Ash, Dr.    +97236973698   
Sponsors and Collaborators
Principal Investigator: Elissa Ash, Dr. Ichilov Hospital
  More Information

Responsible Party: Brainsway Identifier: NCT01464515     History of Changes
Other Study ID Numbers: P-0021
Study First Received: October 25, 2011
Last Updated: January 26, 2015

Keywords provided by Brainsway:
Mild Cognitive Impairment, So Stated
Deep Transcranial Magnetic Stimulation

Additional relevant MeSH terms:
Cognition Disorders
Mild Cognitive Impairment
Neurocognitive Disorders
Mental Disorders processed this record on August 18, 2017